Add to Watchlist
View Current for VTYX
View SuperFeed for VTYX
View Charts for VTYX
Add or remove $VTYX from your watchlists:
Hang tight! We're updating your watchlist data. This might take a minute...
You have not created a stock watchlist.
Create one now to track $VTYX!
Done
Manage Watchlists
Ventyx Biosciences Inc
Health Care
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory d…
more
Conversation Volume
Last 60 days
There is not enough conversation volume about this stock
Key Opinion Leaders
Strongest 30-day focus on $VTYX by total mentions
Real-time Chart
Price Chart for $VTYX
Conviction History
Bullish vs Bearish Conviction over the last 30 days.
This color denotes Market Hours (US/Eastern)
There is not enough conversation volume about this stock
Thread Explorer
Explore popular threads around $VTYX
There are no threads for this stock
Chart Explorer
Explore recent charts, graphs, and media
There are no charts for this stock
Rarely do we see this kind of divergence between value ($SPYV = black line) and growth ($SPYG = red line). Check it out this 5 year chart...
Go to Chart Explorer
Latest News
Get the latest breaking news from the community
There is no recent news for this stock
Loading news, hang tight...
Google Search Trends - Past 12 months
Instantly visualize search trends for this specific symbol
Today
Past 7 days
Past 30 days
Past 60 days
Custom
Company Profile
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Its lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
Market Cap Type: Mid
Close
Date,Time,Temperature
2024-05-01,10,0
2024-05-01,11,0
2024-05-01,12,0
2024-05-01,13,0
2024-05-01,14,0
2024-05-01,15,0
2024-05-01,16,0
2024-05-01,17,0
2024-05-01,18,0
2024-05-01,19,0
2024-05-01,20,0
2024-05-01,21,0
2024-05-01,22,0
2024-05-01,23,0
2024-05-02,0,0
2024-05-02,1,0
2024-05-02,2,0
2024-05-02,3,0
2024-05-02,4,0
2024-05-02,5,0
2024-05-02,6,0
2024-05-02,7,0
2024-05-02,8,0
2024-05-02,9,0
2024-05-02,10,0
2024-05-02,11,0
2024-05-02,12,0
2024-05-02,13,0
2024-05-02,14,0
2024-05-02,15,0
2024-05-02,16,0
2024-05-02,17,0
2024-05-02,18,0
2024-05-02,19,0
2024-05-02,20,0
2024-05-02,21,0
2024-05-02,22,0
2024-05-02,23,0
2024-05-03,0,0
2024-05-03,1,0
2024-05-03,2,0
2024-05-03,3,0
2024-05-03,4,0
2024-05-03,5,0
2024-05-03,6,0
2024-05-03,7,0
2024-05-03,8,0
2024-05-03,9,0
2024-05-03,10,0
2024-05-03,11,0
2024-05-03,12,0
2024-05-03,13,0
2024-05-03,14,0
2024-05-03,15,0
2024-05-03,16,0
2024-05-03,17,0
2024-05-03,18,0
2024-05-03,19,0
2024-05-03,20,0
2024-05-03,21,0
2024-05-03,22,0
2024-05-03,23,0
2024-05-04,0,0
2024-05-04,1,0
2024-05-04,2,0
2024-05-04,3,0
2024-05-04,4,0
2024-05-04,5,0
2024-05-04,6,0
2024-05-04,7,0
2024-05-04,8,0
2024-05-04,9,0
2024-05-04,10,0
2024-05-04,11,0
2024-05-04,12,0
2024-05-04,13,0
2024-05-04,14,0
2024-05-04,15,0
2024-05-04,16,0
2024-05-04,17,0
2024-05-04,18,0
2024-05-04,19,0
2024-05-04,20,0
2024-05-04,21,0
2024-05-04,22,0
2024-05-04,23,0
2024-05-05,0,0
2024-05-05,1,0
2024-05-05,2,0
2024-05-05,3,0
2024-05-05,4,0
2024-05-05,5,0
2024-05-05,6,0
2024-05-05,7,0
2024-05-05,8,0
2024-05-05,9,0
2024-05-05,10,0
2024-05-05,11,0
2024-05-05,12,0
2024-05-05,13,0
2024-05-05,14,0
2024-05-05,15,0
2024-05-05,16,0
2024-05-05,17,0
2024-05-05,18,0
2024-05-05,19,0
2024-05-05,20,0
2024-05-05,21,0
2024-05-05,22,0
2024-05-05,23,0
2024-05-06,0,0
2024-05-06,1,0
2024-05-06,2,0
2024-05-06,3,0
2024-05-06,4,0
2024-05-06,5,0
2024-05-06,6,0
2024-05-06,7,0
2024-05-06,8,0
2024-05-06,9,0
2024-05-06,10,0
2024-05-06,11,0
2024-05-06,12,0
2024-05-06,13,0
2024-05-06,14,0
2024-05-06,15,0
2024-05-06,16,0
2024-05-06,17,0
2024-05-06,18,0
2024-05-06,19,0
2024-05-06,20,0
2024-05-06,21,0
2024-05-06,22,0
2024-05-06,23,0
2024-05-07,0,0
2024-05-07,1,0
2024-05-07,2,0
2024-05-07,3,0
2024-05-07,4,0
2024-05-07,5,0
2024-05-07,6,0
2024-05-07,7,0
2024-05-07,8,0
2024-05-07,9,0
2024-05-07,10,0
2024-05-07,11,0
2024-05-07,12,0
2024-05-07,13,0
2024-05-07,14,0
2024-05-07,15,0
2024-05-07,16,0
2024-05-07,17,0
2024-05-07,18,0
2024-05-07,19,0
2024-05-07,20,0
2024-05-07,21,0
2024-05-07,22,0
2024-05-07,23,0
2024-05-08,0,0
2024-05-08,1,0
2024-05-08,2,0
2024-05-08,3,0
2024-05-08,4,0
2024-05-08,5,0
2024-05-08,6,0
2024-05-08,7,0
2024-05-08,8,0
2024-05-08,9,0
2024-05-08,10,0
2024-05-08,11,0
2024-05-08,12,0
2024-05-08,13,0
2024-05-08,14,0
2024-05-08,15,0
2024-05-08,16,0
2024-05-08,17,0
2024-05-08,18,0
2024-05-08,19,0
2024-05-08,20,0
2024-05-08,21,0
2024-05-08,22,0
2024-05-08,23,0
2024-05-09,0,0
2024-05-09,1,0
2024-05-09,2,0
2024-05-09,3,0
2024-05-09,4,0
2024-05-09,5,0
2024-05-09,6,0
2024-05-09,7,0
2024-05-09,8,0
2024-05-09,9,0
2024-05-09,10,0
2024-05-09,11,0
2024-05-09,12,0
2024-05-09,13,0
2024-05-09,14,0
2024-05-09,15,0
2024-05-09,16,0
2024-05-09,17,0
2024-05-09,18,0
2024-05-09,19,0
2024-05-09,20,0
2024-05-09,21,0
2024-05-09,22,0
2024-05-09,23,0
2024-05-10,0,0
2024-05-10,1,0
2024-05-10,2,0
2024-05-10,3,0
2024-05-10,4,0
2024-05-10,5,0
2024-05-10,6,0
2024-05-10,7,0
2024-05-10,8,0
2024-05-10,9,0
2024-05-10,10,0
2024-05-10,11,0
2024-05-10,12,0
2024-05-10,13,0
2024-05-10,14,0
2024-05-10,15,0
2024-05-10,16,0
2024-05-10,17,0
2024-05-10,18,0
2024-05-10,19,0
2024-05-10,20,0
2024-05-10,21,0
2024-05-10,22,0
2024-05-10,23,0
2024-05-11,0,0
2024-05-11,1,0
2024-05-11,2,0
2024-05-11,3,0
2024-05-11,4,0
2024-05-11,5,0
2024-05-11,6,0
2024-05-11,7,0
2024-05-11,8,0
2024-05-11,9,0
2024-05-11,10,0
2024-05-11,11,0
2024-05-11,12,0
2024-05-11,13,0
2024-05-11,14,0
2024-05-11,15,0
2024-05-11,16,0
2024-05-11,17,0
2024-05-11,18,0
2024-05-11,19,0
2024-05-11,20,0
2024-05-11,21,0
2024-05-11,22,0
2024-05-11,23,0
2024-05-12,0,0
2024-05-12,1,0
2024-05-12,2,0
2024-05-12,3,0
2024-05-12,4,0
2024-05-12,5,0
2024-05-12,6,0
2024-05-12,7,0
2024-05-12,8,0
2024-05-12,9,0
2024-05-12,10,0
2024-05-12,11,0
2024-05-12,12,0
2024-05-12,13,0
2024-05-12,14,0
2024-05-12,15,0
2024-05-12,16,0
2024-05-12,17,0
2024-05-12,18,0
2024-05-12,19,0
2024-05-12,20,0
2024-05-12,21,0
2024-05-12,22,0
2024-05-12,23,0
2024-05-13,0,0
2024-05-13,1,0
2024-05-13,2,0
2024-05-13,3,0
2024-05-13,4,0
2024-05-13,5,0
2024-05-13,6,0
2024-05-13,7,0
2024-05-13,8,0
2024-05-13,9,0
2024-05-13,10,0
2024-05-13,11,0
2024-05-13,12,0
2024-05-13,13,0
2024-05-13,14,0
2024-05-13,15,0
2024-05-13,16,0
2024-05-13,17,0
2024-05-13,18,0
2024-05-13,19,0
2024-05-13,20,0
2024-05-13,21,0
2024-05-13,22,0
2024-05-13,23,0
2024-05-14,0,0
2024-05-14,1,0
2024-05-14,2,0
2024-05-14,3,0
2024-05-14,4,0
2024-05-14,5,0
2024-05-14,6,0
2024-05-14,7,0
2024-05-14,8,0
2024-05-14,9,0
2024-05-14,10,0
2024-05-14,11,0
2024-05-14,12,0
2024-05-14,13,0
2024-05-14,14,0
2024-05-14,15,0
2024-05-14,16,0
2024-05-14,17,0
2024-05-14,18,0
2024-05-14,19,0
2024-05-14,20,0
2024-05-14,21,0
2024-05-14,22,0
2024-05-14,23,0
2024-05-15,0,0
2024-05-15,1,0
2024-05-15,2,0
2024-05-15,3,0
2024-05-15,4,0
2024-05-15,5,0
2024-05-15,6,0
2024-05-15,7,0
2024-05-15,8,0
2024-05-15,9,0
2024-05-15,10,0
2024-05-15,11,0
2024-05-15,12,0
2024-05-15,13,0
2024-05-15,14,0
2024-05-15,15,0
2024-05-15,16,0
2024-05-15,17,0
2024-05-15,18,0
2024-05-15,19,0
2024-05-15,20,0
2024-05-15,21,0
2024-05-15,22,0
2024-05-15,23,0
2024-05-16,0,0
2024-05-16,1,0
2024-05-16,2,0
2024-05-16,3,0
2024-05-16,4,0
2024-05-16,5,0
2024-05-16,6,0
2024-05-16,7,0
2024-05-16,8,0
2024-05-16,9,0
2024-05-16,10,0.125
2024-05-16,11,0